Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 5, Number 6—December 1999
Synopsis

Antimicrobial Resistance with Streptococcus pneumoniae in the United States, 1997–98

Gary V. DoernComments to Author , Angela B. Brueggemann, Holly Huynh, Elizabeth Wingert, and Paul Rhomberg
Author affiliations: University of Iowa College of Medicine, Iowa City, Iowa, USA

Main Article

Table 5

Resistance rates of selected antimicrobial drugs, by study center

Medical center and location No. of Pencillin Ceftriaxone Erythromycin Tetrcycline Chloramphenicol TMP/SMX
isolates % I % R % I % R % I % R % I % R % I % R % I % R
Children’s Hospital & Medical Center, Seattle, WA 50 26.0 12.0 10.0 8.0 0.0 30.0 0.0 24.0 -- 10.0 8.0 34.0
Veteran’s Affairs Medical Center, Portland, OR 24 12.5 4.2 8.3 0.0 0.0 12.5 0.0 12.5 -- 0.0 4.2 25.0
UCSF Medical Center, San Francisco, CA 47 4.3 8.5 6.4 4.3 0.0 12.8 2.1 14.9 -- 6.4 6.4 19.1
UCLA Medical Center, Los Angeles, CA 55 27.3 14.5 20.0 1.8 1.8 18.2 0.0 20.0 -- 10.9 25.5 21.8
Pathology Medical Laboratories, San Diego, CA 51 15.7 2.0 3.9 0.0 0.0 13.7 0.0 11.8 -- 2.0 9.8 9.8
University of Utah Medical Center, Salt Lake City, UT 53 13.2 9.4 9.4 1.9 0.0 17.0 0.0 7.5 5.7 13.2 20.8
Denver Health, Denver, CO 26 7.7 7.7 11.5 0.0 0.0 7.7 0.0 11.5 -- 11.5 3.8 15.4
Good Samaritan Medical Center, Phoenix, AZ 64 11.1 29.6 24.1 11.1 0.0 35.2 0.0 20.4 -- 5.6 11.1 38.9
University Hospital, Albuquerque, NM 51 11.8 5.9 5.9 0.0 0.0 13.7 0.0 7.8 -- 3.9 9.8 11.8
Texas Children’s Hospital, Houston, TX 48 39.6 25.0 26.0 10.4 0.0 43.8 2.1 22.9 -- 14.6 20.8 41.7
Parkland Health & Hospital System, Dallas, TX 36 19.4 11.1 11.1 2.8 0.0 27.8 0.0 22.2 -- 11.1 16.7 22.2
Mayo Clinic, Rochester, MN 48 16.7 6.3 6.3 4.2 0.0 20.8 2.1 10.4 -- 6.3 10.4 16.7
University of Iowa Hospitals and Clinics, Iowa City, IA 49 16.3 22.4 16.3 4.1 0.0 22.4 0.0 20.4 -- 12.2 14.3 22.4
Children’s Hospital, Milwaukee, WI 55 12.7 7.3 7.3 3.6 0.0 10.9 1.8 5.5 -- 3.6 12.7 14.5
Evanston Hospital, Evanston, IL 35 11.4 2.9 2.9 0.0 0.0 14.3 0.0 5.7 -- 0.0 5.7 8.6
Rush-Presbyterian St. Luke’s Medical Center, Chicago, IL 41 14.6 4.9 4.9 2.4 0.0 19.5 0.0 17.1 -- 7.3 2.4 19.5
Clarian Health Methodist Hospital, Indianapolis, IN 55 18.2 7.3 3.6 0.0 1.8 16.4 0.0 7.3 -- 3.6 10.9 12.7
Washington University, St. Louis, MO 55 12.7 16.4 14.5 3.6 0.0 12.7 0.0 9.1 -- 5.5 18.2 12.7
Henry Ford Health System, Detroit, MI 60 21.7 8.3 10.0 3.3 0.0 10.0 0.0 8.3 -- 6.7 15.0 10.0
The Cleveland Clinic Foundation, Cleveland, OH 60 10.0 13.3 11.7 3.3 0.0 20.0 1.7 10.0 -- 6.7 11.7 15.0
Temple University Hospital, Philadelphia, PA 42 7.1 14.3 4.8 9.5 2.4 9.5 0.0 7.1 -- 4.8 2.4 9.5
Geisinger Medical Center, Danville, PA 49 30.6 8.2 12.2 0.0 0.0 20.4 0.0 20.4 -- 12.2 10.2 14.3
SUNY Health Science Center, Syracuse, NY 50 12.0 8.0 8.0 2.0 0.0 8.0 0.0 8.0 -- 6.0 12.0 8.0
University of Rochester Medical Center, Rochester, NY 50 10.0 10.0 10.0 2.0 2.0 10.0 0.0 8.0 -- 6.0 8.0 14.0
Columbia Presbyterian Medical Center, New York, NY 53 18.9 1.9 3.8 0.0 0.0 3.8 0.0 7.5 -- 5.7 5.7 7.5
Dartmouth Hitchcock Medical Center, Lebanon, NH 50 8.0 8.0 4.0 4.0 0.0 10.0 0.0 6.0 -- 6.0 6.0 22.0
Hartford Hospital, Hartford, CT 51 17.6 9.8 9.8 0.0 2.0 5.9 0.0 7.8 -- 2.0 11.8 17.6
Beth Israel Deaconess Medical Center, Boston, MA 41 9.8 4.9 2.4 2.4 0.0 14.6 0.0 9.8 -- 2.4 7.3 9.8
Children’s Hospital, Washington, DC 28 17.9 17.9 21.4 0.0 0.0 28.6 0.0 17.9 -- 3.6 7.1 28.6
University of North Carolina Hospital, Chapel Hill, NC 49 22.4 34.7 26.5 14.3 2.0 36.7 0.0 20.4 -- 16.3 16.3 46.9
Dekalb Medical Center, Decatur, GA 52 32.7 11.5 11.5 1.9 0.0 26.9 0.0 17.3 -- 7.7 3.8 28.8
University of Louisville Hospital, Louisville, KY 48 22.9 10.4 4.2 8.3 0.0 20.8 0.0 6.3 -- 2.1 6.3 18.8
University of South Alabama, Mobile, AL 58 17.2 24.1 17.2 6.9 0.0 37.9 0.0 13.8 -- 13.8 12.1 39.7
Mount Sinai Medical Center, Miami Beach, FL 27 18.5 33.3 25.9 22.2 0.0 29.6 0.0 29.6 -- 25.9 7.4 48.1

I, intermediate resistance; R, resistant; TMP/SMX, trimethoprim/sulfamethoxazole.

Main Article

Page created: December 15, 2010
Page updated: December 15, 2010
Page reviewed: December 15, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external